The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer

Triple Negative Breast Cancer, TNBC, a highly aggressive and metastatic type of breast cancer, is characterized by loss of expression of the estrogen receptor (ER), progesterone receptor (PR), and a lack of overexpression of the human epidermal growth factor receptor 2 (HER2). It is a heterogeneous...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Rebecca, Sabnis, Nirupama, McConathy, Walter J., Lacko, Andras G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826456/
https://www.ncbi.nlm.nih.gov/pubmed/24244833
http://dx.doi.org/10.3390/pharmaceutics5020353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826456/
https://www.ncbi.nlm.nih.gov/pubmed/24244833
http://dx.doi.org/10.3390/pharmaceutics5020353

Ejemplares similares